FDA ap­proves an­oth­er RSV op­tion, this time it's Sanofi and As­traZeneca’s an­ti­body drug for in­fants

The fight against one of the world’s most com­mon res­pi­ra­to­ry virus­es just got an­oth­er weapon.

On Mon­day, the FDA ap­proved Bey­for­tus, an an­ti­body drug co …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.